Related Experiment Videos
[Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution]
Insights
Isovolumic hemodilution effectively manages hemostatic disorders in coronary heart disease (CHD) patients with increased blood viscosity. This intervention normalized hemostasis and improved clinical outcomes in a significant portion of cases.
Area of Science:
- Cardiovascular Medicine
- Hematology
Context:
- Coronary heart disease (CHD) is often associated with hemostatic abnormalities and increased blood viscosity.
- Understanding these hemostatic changes is crucial for effective patient management.
Purpose:
- To determine indications for isovolumic hemodilution in coronary patients.
- To correlate hemostatic parameters with clinical and diagnostic findings in CHD.
- To evaluate the efficacy of isovolumic hemodilution in managing hemostatic disorders.
Summary:
- A study involving 41 coronary patients compared hemostatic parameters (fibrinogen, soluble fibrin, fibrin decomposition products, platelet aggregation, thromboelastograms) with clinical, coronarographic, and bicycle-ergometric findings.
- Increased blood viscosity syndrome was identified in 63% of patients.
- Isovolumic hemodilution was administered to 17 patients, demonstrating effectiveness in controlling hemostatic disorders and leading to clinical improvement in some cases.
Impact:
- Isovolumic hemodilution is a valuable therapeutic option for coronary patients with specific hemostatic derangements.
- Normalization of hemostasis through hemodilution can contribute to improved clinical status in CHD patients.
- This study provides evidence for the clinical utility of isovolumic hemodilution in managing complex cardiovascular conditions.
Abstract:
To specify indications for isovolumic hemodilution, hemostatic parameters (fibrinogen, soluble fibrin, fibrin decomposition products, platelet aggregation, thromboelastograms) were compared with clinical manifestations of coronary heart diseases (CHD) and coronarographic and bicycle-ergometric findings in 41 coronary patients. The increased blood viscosity syndrome was found in 63% of the patients. Isovolumic hemodilution was performed to control the detected disorders in 17 patients. Hemodilution was shown to be an effective means of controlling hemostatic disorders in coronary patients, hemostatic normalization being accompanied with clinical improvement in part of the cases.